Allegra Allergy Tablet, Film Coated
NDC Package 67751-033-01
Package Information
Allegra Allergy (fexofenadine hydrochloride) tablets is adults and children 12 years of age and over take one 180mg tablet with water once a day; do not take more than 1 tablet in 24 hours children under 12 years of age do not use adults 65 years of age and older ask a doctor consumers with kidney disease ask a doctor. This formulation utilizes a tablet, film coated delivery system. Marketed by Navajo Manufacturing Company Inc., this product is identified by NDC 67751-033 and is authorized under FDA application NDA020872.
Identification & Billing
- RxCUI: 997420 - fexofenadine HCl 180 MG 24 HR Oral Tablet
- RxCUI: 997420 - fexofenadine hydrochloride 180 MG Oral Tablet
- RxCUI: 997422 - Allegra 180 MG Oral Tablet
- RxCUI: 997422 - fexofenadine hydrochloride 180 MG Oral Tablet [Allegra]
Clinical Specifications
Regulatory & Marketing
Hierarchy Structure
- 67751 - Navajo Manufacturing Company Inc.
- 67751-033 - Allegra Allergy
- 67751-033-01 - 1 TABLET, FILM COATED in 1 BLISTER PACK
- 67751-033 - Allegra Allergy
The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.
* Please review the full disclaimer at the bottom of this page.
Other Available Packages
The following commercial packages are registered under the same Product NDC (67751-033). Click a package code to view its specific billing and regulatory data.
* Please review the full disclaimer at the bottom of this page.
Frequently Asked Questions
What is the distribution configuration for this product package?
The code 67751-033-01 identifies a specific commercial package of 1 tablet, film coated in 1 blister pack of Allegra Allergy, a human over the counter drug labeled by Navajo Manufacturing Company Inc.. This tablet, film coated is formulated for oral use and contains fexofenadine hydrochloride as the active substance.
Is this product currently listed with the FDA?
Yes, this product is active and verified within the NDC Directory. It was introduced to the market by Navajo Manufacturing Company Inc. on May 12, 2015. The current certification is valid through December 31, 2027.
How is this Navajo Manufacturing Company Inc. product billed for insurance claims?
For medical billing and reimbursement, this package follows the 11-digit CMS format: 67751003301. The table below illustrates the segment conversion from the 10-digit labeler code to the 11-digit provider format.
11-Digit Code Conversion
Billing payers usually require a 5-4-2 segment configuration. Below is the conversion from the 10-digit package format to the 11-digit billing format:
Note: The zero is added to the Product segment to maintain the 5-4-2 structure.